CASI Pharmaceuticals (CASIF) Shares Outstanding (Diluted Average) (2020 - 2025)

CASI Pharmaceuticals has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $18.5 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 20.85% year-over-year to $18.5 million; the trailing twelve-month figure through Dec 2025 stood at $18.5 million (up 20.85% YoY), and the FY2025 full-year result was $18.5 million, up 20.85% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $18.5 million, up from $15.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $18.5 million in Q4 2025, with the low at $13.4 million in Q4 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $15.0 million across 4 years, with a median of $14.5 million in 2021.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) rose 23.23% — and 2024, when it advanced 14.82%.
• CASI Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $13.6 million in 2021, then retreated by 1.84% to $13.4 million in 2023, then rose by 14.82% to $15.3 million in 2024, then climbed by 20.85% to $18.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $18.5 million (Q4 2025), $15.5 million (Q1 2025), and $15.3 million (Q4 2024), per Business Quant data.